Risk Stratification in Newly Diagnosed Transplant Ineligible Multiple Myeloma
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-61872-2_3
Reference84 articles.
1. Smith BD, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758–65.
2. Turesson I, et al. Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all ages groups in the population by rapidly changing age distribution in the clinic. Mayo Clinic Proc. 2010;85:225–30.
3. Brenner H, et al. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood. 2008;111:2521–6.
4. Kumar SK. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516–20.
5. Kumar S, Berdeja JG, Niesvizky R, et al. Long-term ixazomib maintenance is tolerable and improves depth of response following ixazomib-lenalidomide-dexamethasone induction in patients with previously untreated multiple myeloma: phase 2 study results. ASH Annual Meeting Abstracts 2014; abstract 82; 2013.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3